Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients
Status:
Completed
Trial end date:
2018-07-22
Target enrollment:
Participant gender:
Summary
Obesity among breast cancer survivors is known to be associated with recurrence and other
co-morbidities. However, there have been no studies on weight reduction program combining
diet and anti-obesity drug for obese breast cancer survivors. The purpose of this randomized
clinical trial is to examine the effects of Mediterranean Diet and naltrexone/bupropion
treatment on inflammation and metabolic risk factors in overweight or obese breast cancer
patients after breast cancer treatment.